FNTA:FNTB transfers farnesyl to GBP1

Stable Identifier
R-HSA-9948016
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Synonyms
Farnesyltransferase complex farnesylates GBP1, GBP1 prenylation
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Guanylate-binding protein 1 (GBP1) is farnesylated at cysteine 589 (C589) (Nantais et al., 1996; Fres JM et al., 2010; Fisch et al., 2019; Shydlovskyi et al., 2017). Farnesylation is a type of prenylation in which a 15-carbon farnesyl (FARN) isoprenoid group, donated by farnesyl diphosphate (FPP), is covalently attached to a cysteine residue on a protein. This reaction is catalyzed by the enzyme farnesyltransferase (FNT), a heterodimer composed of an alpha subunit, FNTA (shared with another prenylating enzyme, geranylgeranyltransferase or GGTase), and a unique beta subunit, FNTB (Long SB et al., 2001; deSolms et al., 2003). The FNTA:FNTB complex recognizes the CAAX box motif at the C-terminus of target proteins, where C = cysteine, A = any aliphatic amino acid, and X = any amino acid. In the case of GBP1, the CAAX motif is CTIS. In the absence of nucleotides, the farnesyl group of GBP1 is sequestered in a hydrophobic pocket, maintaining the protein in an inactive, monomeric conformation (Lorenz et al., 2020; Sistemich et al., 2020). Upon GTP binding, farnesylated GBP1 undergoes a nucleotide-dependent "farnesyl switch," which releases the farnesyl tail from the hydrophobic pocket, enabling membrane binding and polymerization into large structures (Sistemich et al., 2020; Kuhm et al., 2025). Farnesylated GBP1 localizes to the microbial membranes (reviewed by Tretina K et al., 2019). For instance, GBP1 localizes to the lipopolysaccharide (LPS)-rich outer membranes of cytosolic Gram-negative bacteria, where it oligomerizes and facilitates the assembly of a caspase-4–activating platform (Santos et al., 2020; Wandel et al., 2020; Dickinson et al., 2023).
Once prenylated, CAAX-containing proteins undergo proteolytic cleavage of the terminal AAX tripeptide. This reaction is catalyzed by endopeptidases such as RAS-converting enzyme 1 (RCE1), resulting in exposure of the prenylated cysteine as the new C-terminus. The exposed cysteine can then be methylated by isoprenylcysteine carboxyl methyltransferase (ICMT) (reviewed by Wang M & Casey PJ 2016; Cansado J 2017). This sequence of post-translational modifications is considered a common mechanism by which CAAX-containing proteins, including GBP1, GBP2, and GBP5, are activated. However, there is no direct evidence for proteolytic removal of the C-terminal tripeptide or ICMT-mediated methylation of the C-terminal cysteine in GBPs; therefore, these steps are not depicted here.
Literature References
PubMed ID Title Journal Year
28645896 Nucleotide-dependent farnesyl switch orchestrates polymerization and membrane binding of human guanylate-binding protein 1

Shydlovskyi, S, Zienert, AY, Ince, S, Dovengerds, C, Hohendahl, A, Dargazanli, JM, Blum, A, Günther, SD, Kladt, N, Stürzl, M, Schauss, AC, Kutsch, M, Roux, A, Praefcke, GJK, Herrmann, C

Proc Natl Acad Sci U S A 2017
8830800 Prenylation of an interferon-gamma-induced GTP-binding protein: the human guanylate binding protein, huGBP1

Nantais, DE, Schwemmle, M, Stickney, JT, Vestal, DJ, Buss, JE

J Leukoc Biol 1996
20348589 Purification of the CaaX-modified, dynamin-related large GTPase hGBP1 by coexpression with farnesyltransferase

Fres, JM, Muller, S, Praefcke, GJ

J Lipid Res 2010
31268602 Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis

Fisch, D, Bando, H, Clough, B, Hornung, V, Yamamoto, M, Shenoy, AR, Frickel, EM

EMBO J 2019
31330084 Farnesylation of human guanylate-binding protein 1 as safety mechanism preventing structural rearrangements and uninduced dimerization

Lorenz, C, Ince, S, Zhang, T, Cousin, A, Batra-Safferling, R, Nagel-Steger, L, Herrmann, C, Stadler, AM

FEBS J 2020
11687658 The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics

Long, SB, Hancock, PJ, Kral, AM, Hellinga, HW, Beese, LS

Proc. Natl. Acad. Sci. U.S.A. 2001
32087202 The Molecular Mechanism of Polymer Formation of Farnesylated Human Guanylate-binding Protein 1

Sistemich, L, Kutsch, M, Hämisch, B, Zhang, P, Shydlovskyi, S, Britzen-Laurent, N, Stürzl, M, Huber, K, Herrmann, C

J Mol Biol 2020
Participants
Participates
Catalyst Activity

protein farnesyltransferase activity of FNTA:FNTB [cytosol]

Orthologous Events
Authored
Reviewed
Created
Cite Us!